Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More Pharma Industry News Telix Pharmaceuticals to acquire ImaginAb assets to advance radiopharmaceutical development Telix Pharmaceuticals Limited, a global leader in therapeutic and diagnostic radiopharmaceuticals, has announced a strategic acquisition of assets… byPallavi MadhirajuJanuary 13, 2025